In addition to ADCC, NEO-201 has different mechanisms of action to kill cancer cells expressing its target antigen, including CDC and the blockade of the CEACAM5/CEACAM1 immune checkpoint inhibitory pathway [15]. This evidence concerns the gene CEACAM5 and cancer.